The distribution of Intravenous Immunoglobulin (IVIg) has become a focal point for healthcare providers aiming to improve patient outcomes. As the market grows, projected to reach USD 18.99 billion by 2035, effective distribution mechanisms are essential in ensuring that patients have access to necessary therapies. This growth trajectory, accompanied by a CAGR of 3.96%, underscores the...